Penumbra
PEN
#1768
Rank
ยฃ8.44 B
Marketcap
ยฃ215.76
Share price
-2.61%
Change (1 day)
14.21%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Revenue for Penumbra (PEN)

Revenue in 2025 (TTM): ยฃ1.01 Billion

According to Penumbra's latest financial reports the company's current revenue (TTM ) is ยฃ1.00 Billion. In 2024 the company made a revenue of ยฃ0.95 Billion an increase over the revenue in the year 2023 that were of ยฃ0.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Penumbra from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ1.01 B6.45%
2024 ยฃ0.95 B14.57%
2023 ยฃ0.83 B18.66%
2022 ยฃ0.70 B26.43%
2021 ยฃ0.55 B34.71%
2020 ยฃ0.41 B-1.51%
2019 ยฃ0.41 B19.09%
2018 ยฃ0.35 B41.94%
2017 ยฃ0.24 B15.72%
2016 ยฃ0.21 B69.94%
2015 ยฃ0.12 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Inari Medical
NARI
ยฃ0.43 B-56.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
ยฃ1.10 B 10.75%๐Ÿ‡บ๐Ÿ‡ธ USA